• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Graphite Bio Inc (NQ: GRPH )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Mar 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Graphite Bio Inc

    < Previous 1 2 Next >
    Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics
    From Graphite Bio, Inc.
    Via Business Wire
    GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH
    From Kahn Swick & Foti, LLC
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. (Nasdaq – CERE), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc.
    From Brodsky & Smith LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EngageSmart, Inc. (NYSE – ESMT), WaveDancer, Inc. (Nasdaq – WAVD), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hawaiian Holdings, Inc. (Nasdaq – HA), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EngageSmart, Inc. (NYSE – ESMT), WaveDancer, Inc. (Nasdaq – WAVD), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR),
    From Brodsky & Smith LLC
    Via GlobeNewswire
    GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH
    From Kahn Swick & Foti, LLC
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WaveDancer, Inc. (Nasdaq – WAVD), Selecta Biosciences, Inc. (Nasdaq – SELB), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    GRPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Graphite Bio, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    LENZ Therapeutics and Graphite Bio Announce Merger Agreement
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Announces Departure of Chief Financial Officer
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2022 Financial Results
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Announces Process to Explore Strategic Alternatives and Corporate Restructuring
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel (nula-cel) for Sickle Cell Disease
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Presents Preclinical Data for Novel Sequencing Method Used to Determine Gene Editing Outcomes at 64th ASH Annual Meeting
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx Conference
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Reports Recent Business Progress and Third Quarter 2022 Financial Results
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Announces Abstracts Accepted for Upcoming 64th ASH Annual Meeting and Exposition
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Announces Participation in 50th Annual Sickle Cell Disease Association of America National Convention
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Announces Participation in Morgan Stanley 20th Annual Global Healthcare Conference
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Reports Recent Business Progress and Second Quarter 2022 Financial Results
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Doses First Patient with Investigational Gene Editing Therapy GPH101 for Sickle Cell Disease
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Announces Participation in Jefferies Healthcare Conference
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio, Inc. (NASDAQ:GRPH) Investor Alert: Investigation over Potential Wrongdoing
    San Diego, CA -- (SBWIRE) -- 05/26/2022 -- An investigation on behalf of current long-term investors in shares of Graphite Bio, Inc. (NASDAQ:GRPH) was announced over potential breaches of fiduciary... 
    Via SBWire
    Graphite Bio Presents Preclinical Gene Replacement Data for GPH102 for Beta-thalassemia at the ASGCT 25th Annual Meeting
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Reports Recent Business Progress and First Quarter 2022 Financial Results
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Announces Participation in Upcoming Investor Conferences
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Announces U.S. FDA Fast Track Designation Granted to GPH101 for the Treatment of Sickle Cell Disease
    From Graphite Bio, Inc.
    Via Business Wire
    Graphite Bio Announces Participation in the ASGCT 25th Annual Meeting Including Oral Presentation About Beta-thalassemia Program
    From Graphite Bio, Inc.
    Via Business Wire
    NASDAQ:GRPH Shareholder Notice: Investigation over Possible Securities Laws Violations by Graphite Bio, Inc.
    San Diego, CA -- (SBWIRE) -- 04/13/2022 -- Graphite Bio, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
    Via SBWire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.